LB 71148

Drug Profile

LB 71148

Alternative Names: LK 71148

Latest Information Update: 22 Aug 2007

Price : $50

At a glance

  • Originator LG Chem Investment
  • Class Antivirals; Oligopeptides
  • Mechanism of Action HIV protease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 01 Sep 1998 No-Development-Reported for HIV infections treatment in South Korea (PO)
  • 11 Sep 1996 An in vitro study has been added to the antimicrobial activity section
  • 15 Mar 1996 A study has been added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top